Director, Structural Heart Disease Program
Mid-Atlantic Permanente Medical Group
Benjamin Z. Galper, MD, MPH, FACC was appointed director of the Structural Heart Disease Program at the Mid-Atlantic Permanente Medical Group (MAPMG) in 2016. In this role Dr. Galper has vastly expanded the breadth of percutaneous structural heart procedures offered to patients at MAPMG including: TAVR, Mitraclip, Watchman, and transcatheter pulmonary and mitral valve replacement. He has established a streamlined one-day pre-procedure evaluation process for all structural heart interventions and instituted a fast-track post-TAVR care protocol which has led to average length of stay after TAVR of 1.4 days with two-thirds of patients being discharged the following day.
Dr. Galper is board certified in internal medicine, cardiology, interventional cardiology, and peripheral vascular intervention. Prior to joining MAPMG, Dr. Galper completed fellowships in cardiovascular medicine, interventional cardiology, structural heart intervention and peripheral vascular intervention at Brigham and Women’s Hospital. Previously, he completed internal medicine internship and residency at Columbia University Medical Center where he also served as Chief Medical Resident. Dr. Galper received his medical degree from Albert Einstein College of Medicine graduating with distinction in cardiovascular medicine and clinical research. During medical shool he also earned a Masters of Public Health from the Harvard School of Public Health with a focus in health policy and management. Born and raised in Boston, he earned his bachelors degree in American History from Harvard College, graduating with honors.
Dr. Galper has been active in health policy and in organized medicine. He currently serves on the American Medical Political Action Committee Board of Directors. He is a recent graduate of the American College of Cardiology (ACC) Leadership Academy and serves on the ACC Health Affairs Committee. Dr. Galper also has an interest in clinical research and cost-effective analysis. He has published numerous papers on the cost-effectiveness of new technologies and therapies in cardiology.
Thursday, May 2
9:00 AM – 10:30 AM
Thursday, May 2
12:30 PM – 2:00 PM
Friday, May 3
12:30 PM – 1:50 PM